Skip to main content
. 1998 May 18;141(4):1061–1071. doi: 10.1083/jcb.141.4.1061

Figure 7.

Figure 7

(A) In vitro translation of mouse Eva transcript. In vitro translation was performed in the absence (lanes 1, 3, and 5) or in the presence (lanes 2, 4, and 6) of canine pancreatic microsomal membranes. Translated polypeptides were fractionated through a 12% SDS-PAGE gel and then analyzed by fluorography. Lanes 1 and 2: no RNA as negative control. Lanes 3 and 4: Saccharomyces cerevisiae α-factor mRNA, used as positive control for both translation and glycosylation. The α-factor and the core-glycosylated precursor have molecular weights of 18.6 and 32 kD, respectively. Lanes 5 and 6, Eva mRNA. Lanes 7 and 8: Eva mRNA as in lane 6 or treated with the enzyme endo-H. Positions of molecular mass markers (in kDs) are indicated on the right. (B) Cellular localization and immunoblot of chimeric EVA. Left, anti-myc immunofluorescence on CHO cells transfected with either pcDNA.3 vector (top) or Eva.myc vector (bottom). Right, anti-myc immunoblot on Triton X-100 lysates from the same cells. (C) Anti-EVA immunoblot. Western analysis with rabbit anti-EVA serum of Triton X-100 lysates from CHO cells transfected with either pcDNA.3 vector or Eva.myc vector and lysates in SDS of thymic epithelial cell lines A89A and TNC.R3.1. (D) EVA recovery in insoluble cell fraction. TNC.R3.1 and A89A cells were lysed in hypotonic buffer and separated into three fractions: P1, pellet of low-speed centrifugation; P100, pellet recovered after 100,000 g centrifugation, S100, soluble fraction. Equivalent amounts of all samples were resolved by SDS-PAGE in a 5–15% gradient gel and immunoblotted with rabbit anti-EVA antiserum, anti-actin and anti-src mAbs. EVA is exclusively present in the P1 fraction of TNC.R3.1 cells.